Target intelligence / Profile preview

Ribosomal protein L39 pseudogene 18 (RPL39P18)

Target: RPL39P18
Molecular classification: Pseudogene

Overview

Ribosomal protein L39 pseudogene 18 (RPL39P18) is a processed pseudogene, meaning it is a non-functional segment of DNA that originated from the functional ribosomal protein L39 gene. RPL39P18 does not code for a protein and is considered a genomic relic with no demonstrated biological function or disease association. By definition, pseudogenes like RPL39P18 are not considered therapeutic targets, nor do they have known clinical relevance as biomarkers or safety concerns[3][7].

Other names: RPL39_7_347[3][7]Ribosomal protein L39 pseudogene 18

Mechanism of action

No drugs act on this pseudogene

Beyond the preview

Go deeper on Ribosomal protein L39 pseudogene 18 (RPL39P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L39 pseudogene 18 (RPL39P18).

Explore the full profile